Case Reports

Synchronous presentation of advanced rectal and intermediate-risk prostate cancers: a multidisciplinary approach


 

Primary prostate and colorectal carcinomas represent the most common primary cancers in men in the United States;1 however, rarely do the two cancers present within the same patient, and only anecdotal reports have identified synchronous presentation.2–6 Although a primary surgical approach has been described in most of those reports, 2–4 we here report the successful use of preoperative chemoradiotherapy followed by rectal tumor resection in the community setting for a patient with synchronous presentation of primary prostate and rectal carcinomas.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

FDA Panel Backs Axitinib for Advanced Kidney Cancer
MDedge Hematology and Oncology
Panel Endorses Surveillance for Low-Risk Prostate Cancer
MDedge Hematology and Oncology
Multiparametric Magnetic Resonance Imaging Identifies Candidates for Prostate Cancer Surveillance
MDedge Hematology and Oncology
Despite Guidelines, Elderly Are Getting Cancer Tests
MDedge Hematology and Oncology
Combining MRI With Prostate Ultrasound Biopsy Bests Biopsy Alone
MDedge Hematology and Oncology
Prostate Cancer Deaths: Annual Screen Not Superior to Usual Care
MDedge Hematology and Oncology
FDA Approves Axitinib for Advanced Kidney Cancer
MDedge Hematology and Oncology
ASCO GU to Spotlight Prostate Cancer Drugs MDV3100 and Radium-223
MDedge Hematology and Oncology
Severe and rapid cardiac toxicity from sunitinib therapy in a patient with metastatic renal cell carcinoma
MDedge Hematology and Oncology
Community-Based Surveillance in Clinical Stage I Germ Cell Tumors
MDedge Hematology and Oncology